3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
12
Prostatic Neoplasms
9
Neoplasms
9
Lung Neoplasms
6
Endometrial Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
4
Oropharyngeal Neoplasms
4
Melanoma
4
Colorectal Neoplasms
4
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Leukemia, Myeloid, Acute
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Rectal Neoplasms
2
Meningioma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leiomyoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Trauma, Nervous System
1
Interventions
fludarabine phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Whole-Body Irradiation
2
Tacrolimus
2
Methotrexate
2
Cyclophosphamide
2
treosulfan
1
thymoglobulin
1
ravulizumab
1
X-Rays
1
Sirolimus
1
Observation
1
Mycophenolic Acid
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Busulfan
1
Bone Marrow Transplantation
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemoglobinuria, Paroxysmal
×
Observation
×
1 year
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled